Associate, Patent Attorney
Andrew is a member of our life sciences patent team.
He has a BA(Hons) degree in Natural Sciences from the University of Cambridge and a PhD from the University of Liverpool. His doctoral research focused on finding regulatory transcription factors affecting the plant circadian clock.
Andrew joined Mewburn Ellis LLP in 2015 and qualified as a Chartered Patent Attorney in 2018.